Assyro AI

Orange Book product · Generic (ANDA)

LYPQOZET

ATORVASTATIN CALCIUM; EZETIMIBE

Generic (ANDA)ANDA 206084RX PHARMOBEDIENT

At a glance

Apr 26, 2017

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 26, 2017

    9 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ATORVASTATIN CALCIUM; EZETIMIBE

Strength

EQ 10MG BASE;10MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 206084

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ATORVASTATIN CALCIUM; EZETIMIBE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.